AGC Inc., a manufacturer of glass, chemicals, and high-tech materials, has entered into an agreement with Boehringer Ingelheim to acquire Malgrat Pharma Chemicals S.L.U. (MPC), a subsidiary of Boehringer Ingelheim that manufactures synthetic pharmaceutical active ingredients for the group. By acquiring MPC, AGC will have its first FDA-registered site in Europe in the synthetic pharmaceutical CDMO business.  The deal…